CLINICAL_TRIALS
trial_result
· 2016-11-02
Clinical Trial Update: A Study of Aleglitazar in Type 2 Diabetes Patients With Moderate Renal Impairment [Phase 2]
Summary
Clinical trial update on Aleglitazar in patients with type 2 diabetes and moderate renal impairment. The Phase 2 study has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Diabetes Mellitus Type 2 | Phase 2 | Status: COMPLETED